Showing results (171-180 of 179) with videos related to
Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 179 results.
Medrxiv : the Preprint Server for Health Sciences|April 20, 2022
Immune Correlates Analysis of a Single Ad26.COV2.S Dose in the ENSEMBLE COVID-19 Vaccine Efficacy Clinical TrialYouyi Fong, Adrian B McDermott, David Benkeser, et al.Science (New York, N.Y.)|July 2, 2021
Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variantsLingshu Wang, Tongqing Zhou, Yi Zhang, et al.Immunity|March 17, 2019
Longitudinal Analysis Reveals Early Development of Three MPER-Directed Neutralizing Antibody Lineages from an HIV-1-Infected IndividualShelly J Krebs, Young D Kwon, Chaim A Schramm, et al.Iscience|November 10, 2025
Immune correlates analysis of antibody responses against SARS-CoV-2 variants in the ENSEMBLE vaccine efficacy trialAlex Luedtke, Youyi Fong, Lars van der Laan, et al.Science (New York, N.Y.)|August 13, 2021
Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variantsAmarendra Pegu, Sarah E O'Connell, Stephen D Schmidt, et al.Science (New York, N.Y.)|May 15, 2025
Precise targeting of HIV broadly neutralizing antibody precursors in humansTom G Caniels, Madhu Prabhakaran, Gabriel Ozorowski, et al.Cell|April 21, 2022
mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits similar B cell expansion, neutralizing responses, and protection from OmicronMatthew Gagne, Juan I Moliva, Kathryn E Foulds, et al.Science (New York, N.Y.)|May 15, 2025
Vaccination with mRNA-encoded nanoparticles drives early maturation of HIV bnAb precursors in humansJordan R Willis, Madhu Prabhakaran, Michelle Muthui, et al.Nature|April 1, 2022
Defining the risk of SARS-CoV-2 variants on immune protectionMarciela M DeGrace, Elodie Ghedin, Matthew B Frieman, et al.Pageof 18